HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Passalacqua Selected Research

Rhinitis

11/20192019 ARIA Care pathways for allergen immunotherapy.
6/2017Nasal budesonide efficacy for nasal nitric oxide and nasal obstruction in rhinitis.
1/2017Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period.
1/2016Local allergic rhinitis: entopy or spontaneous response?
1/2015Allergen immunotherapy in asthma; what is new?
8/2014Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children.
2/2014Specific immunotherapy in asthma: a comprehensive review.
3/2012Clinical and cytologic characteristics of allergic rhinitis in elderly patients.
1/2012Allergic and non-allergic rhinitis in swimmers: clinical and cytological aspects.
1/2012The functional connection between oral allergy syndrome and united airways disease assessed by oral challenge.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Passalacqua Research Topics

Disease

73Asthma (Bronchial Asthma)
05/2022 - 04/2002
71Hypersensitivity (Allergy)
10/2021 - 04/2002
31Allergic Rhinitis
10/2021 - 12/2003
23Rhinitis
11/2019 - 03/2003
13Inflammation (Inflammations)
04/2022 - 03/2007
10Food Hypersensitivity (Food Allergy)
01/2019 - 07/2009
9Atopic Dermatitis (Atopic Eczema)
05/2022 - 07/2007
8Anaphylaxis (Anaphylactic Shock)
10/2021 - 04/2002
7Bites and Stings (Sting)
12/2019 - 03/2009
4COVID-19
01/2022 - 05/2020
3Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2014
3Milk Hypersensitivity (Milk Allergy)
06/2012 - 07/2009
2Infections
02/2021 - 04/2012
2Conjunctivitis
01/2017 - 03/2012
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017 - 01/2016
2Urticaria (Hives)
07/2015 - 07/2005
2Angioedema
07/2015 - 08/2005
2Dyspnea (Shortness of Breath)
01/2015 - 01/2014
2Cough
01/2015 - 08/2005
2Osteoporosis
10/2011 - 09/2011
2Seasonal Allergic Rhinitis (Hay Fever)
05/2009 - 03/2005
2Chronic Urticaria
01/2007 - 07/2005
1Nasal Polyps (Nasal Polyp)
05/2022
1Rhinosinusitis
05/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Fistula
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Nasal Obstruction
06/2017
1Confusion (Bewilderment)
02/2017
1Idiopathic Pulmonary Fibrosis
01/2017
1Lung Diseases (Lung Disease)
01/2017
1Dust Mite Allergy
11/2016
1Immune System Diseases (Immune Disorders)
01/2016
1Egg Hypersensitivity (Egg Allergy)
07/2015
1Hypotension (Low Blood Pressure)
07/2015
1Mastocytosis
07/2015
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
01/2015

Drug/Important Bio-Agent (IBA)

47AllergensIBA
02/2020 - 01/2003
23Immunoglobulin E (IgE)IBA
07/2021 - 12/2003
14Biological ProductsIBA
04/2022 - 01/2016
12Arthropod VenomsIBA
12/2018 - 01/2008
10Adrenal Cortex Hormones (Corticosteroids)IBA
02/2021 - 08/2006
9CytokinesIBA
01/2017 - 03/2005
6Monoclonal AntibodiesIBA
10/2021 - 04/2007
6mepolizumabIBA
02/2021 - 01/2016
6Pharmaceutical PreparationsIBA
02/2020 - 08/2006
5TabletsIBA
01/2021 - 01/2016
4Omalizumab (Xolair)FDA Link
01/2020 - 07/2007
4Interleukin-5 (Interleukin 5)IBA
02/2019 - 01/2017
3VaccinesIBA
02/2021 - 01/2016
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 08/2011
3SteroidsIBA
10/2019 - 08/2006
3Tryptases (Tryptase)IBA
07/2015 - 03/2009
3Histamine Antagonists (Antihistamines)IBA
12/2012 - 07/2005
3LatexIBA
09/2012 - 01/2003
2dupilumabIBA
05/2022 - 01/2016
2VenomsIBA
02/2020 - 01/2013
2benralizumabIBA
01/2020 - 01/2016
2Biomarkers (Surrogate Marker)IBA
02/2018 - 01/2016
2Budesonide (Pulmicort)FDA LinkGeneric
06/2017 - 01/2009
2Muscarinic AntagonistsIBA
06/2017 - 01/2014
2Interleukin-13IBA
01/2017 - 01/2016
2anti-IgE antibodiesIBA
08/2016 - 01/2016
2Vitamin DFDA LinkGeneric
01/2014 - 09/2011
2Bronchodilator Agents (Bronchodilators)IBA
01/2014 - 06/2005
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2010 - 08/2005
2levocetirizineFDA LinkGeneric
10/2008 - 07/2005
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2007 - 11/2005
2Methacholine Chloride (Methacholine)FDA Link
03/2005 - 12/2003
1GoldIBA
01/2022
1COVID-19 VaccinesIBA
10/2021
1trichostatin A (A 300)IBA
01/2021
1guar gum (guaran)IBA
01/2020
1lipid transfer protein (glycolipid transfer protein)IBA
01/2020
1AntibodiesIBA
01/2020
1Tyrosine (L-Tyrosine)FDA Link
12/2019
1LipocalinsIBA
01/2018
1AlbuminsIBA
01/2018
1Interleukin-5 Receptors (Interleukin 5 Receptor)IBA
01/2018
1Midazolam (Versed)FDA LinkGeneric
06/2017
1GSK573719IBA
06/2017
1AerosolsIBA
11/2016
1Interleukin-4 (Interleukin 4)IBA
01/2016
1GlucocorticoidsIBA
01/2016
1InterleukinsIBA
01/2016
1PeriostinIBA
01/2016
1reslizumabIBA
01/2016
1Humanized Monoclonal AntibodiesIBA
01/2016
1Nasal SpraysIBA
01/2015
1AntigensIBA
02/2014
1Interleukin-2 (IL2)IBA
02/2013

Therapy/Procedure

59Immunotherapy
01/2020 - 04/2002
25Therapeutics
04/2022 - 10/2003
12Drug Therapy (Chemotherapy)
01/2020 - 11/2003
8Precision Medicine
01/2021 - 01/2016
1Injections
10/2021
1Conservative Treatment
01/2021
1Decompression
01/2021
1Biological Therapy
05/2020
1Self Administration (Administration, Self)
01/2020